Navigation Links


RRMS at Biology News

RRMS at Biology Products
RRMS at Biology Technology
RRMS at Medicine News

Help at hand for RRMS patients

A revolutionary research study hints at the evidence that COPAXONE? (glatiramer acetate injection) may offer protection from axonal injury and induced neuronal metabolic recovery in patients with relapsing remitting multiple sclerosis (RRMS). // COPAXONE? (glatiramer acetate injection) is a selective MHC class II modulator. COPAXONE? is indicated for the reduction of the frequency of...
RRMS at Medicine Products
RRMS at Medicine Technology

Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)

JERUSALEM, & LUND, Sweden--(BUSINESS WIRE)--May 1, 2007 - TevaPharmaceutical Industries Ltd. and Active Biotech AB todayannounced that data from a 36-week, randomized, double-blind,placebo-controlled Phase IIb study demonstrated that an oral 0.6 mgdose of laquinimod given daily significantly reduced magneticresonance imaging (MRI) disease activity by 38 percent in RRMSpatients and was w...

Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)

JERUSALEM--(BUSINESS WIRE)--Apr 17, 2007 - A 9-month, randomized,double-blind, parallel-group Phase II study of 90 patientscomparing a 40 mg dose of COPAXONE(R) given daily to the currentlyapproved COPAXONE(R) 20 mg dose showed a 38 percent greaterreduction in inflammatory disease activity as measured by magneticresonance images (MRI) of the brain. In addition, patients takingCOPAXONE(R) 40...

First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

KANSAS CITY, Mo.--(BUSINESS WIRE)--Apr 11, 2007 - A comparison ofthe long-term economic outcomes of four immunomodulatory drugtherapies combined with symptom management versus symptommanagement alone revealed that COPAXONE(R) (glatiramer acetateinjection) was the most cost-effective treatment strategy forrelapsing-remitting multiple sclerosis (RRMS). The study providesthe first pharmacoecon...
Other TagsORGORGORGORGORGORGORGORGWifeCheckedUTIUTIUTIUTIUTIUTIUTIUTIFolkregarding
(Date:10/10/2008)...y to blame , , FRIDAY, Oct. 10 (HealthDa...o have diabetes, being depressed was associated wi... , Publishing in the October issue of the Jou...om the University of Washington tracked 10,704 Med...o had diabetes and were enrolled in a disease mana...
(Date:10/10/2008)...excellence in the implementation of electronic hea... Management Systems Society (HIMSS) announces the ...zational, Ambulatory and Community Health Organiza...o, IL (PRWEB) October 10, 2008 -- Honoring excelle...ords (EHRs), the Healthcare Information and Manag...
(Date:10/10/2008)...-- The Johns Hopkins University School,of Medicine...am,"Optimizing Adjuvant Breast Cancer Strategies:...nt recent key research data on the latest advances...vancements in the treatment of breast cancer have,...binations that are,increasingly tailored to the sp...
(Date:10/10/2008)... -- A nationally recognized faculty will,present t...ith breast,cancer in the multimedia course "Optimi...rkers to Treatment Selection" during National Brea... practicing oncologists and other interested,healt...patient care,advances. This accredited course offe...
Breaking Medicine News(10 mins):Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
(Date:10/10/2008)...s report on a previously unknown relationship betw...eir mitochondria a cell,s energy makers. Stem cell...r capacity to differentiate and are more likely to...week in JBC, could lead to methods of enriching th...c use and may provide some insights into the role ...
(Date:10/10/2008)...ickleback fish, Gasterosteus aculeatus , is one o...d, and has been a particularly useful model for un...e history and morphology caused by different ecolo...vels from molecular and genetic to developmental a...lation level, it has proven far more complex than ...
(Date:10/10/2008)...d motherhood may make us all go a little gooey, bu...ng to mental health researchers at The Australian ...he Centre for Mental Health Research (CMHR) at ANU...t pregnancy affects their cognitive functions, the...dings have been released as part of Mental Health ...
(Date:10/9/2008)...te change exceed life,s ability to respond? Biodiv..., 2008 issue of the journal, Science , illustrate... Smithsonian Tropical Research Institute in Panama...emely diverse region of rainforest and coral reefs...t of global warming. Some disagree, arguing that t...
Breaking Biology News(10 mins):Fitness in a changing world 2Fitness in a changing world 3Pregnancy not turning minds to mush: Study 2Smithsonian perspective: Biodiversity in a warmer world 2SpongeTech Delivery Systems Inc to Donate to The Darryl Strawberry Foundation 21 21 15623 1SpongeTech Delivery Systems Inc to Donate to The Darryl Strawberry Foundation 21 21 15623 2Olympus Corporation of the Americas Names Mark Gumz President 26 CEO 15621 1Olympus Corporation of the Americas Names Mark Gumz President 26 CEO 15621 2Olympus Corporation of the Americas Names Mark Gumz President 26 CEO 15621 3American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 15619 1American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 15619 2American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 15619 3American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 15619 4Derma Sciences Raises 246 1 Million Through Private Placement 15617 1Derma Sciences Raises 246 1 Million Through Private Placement 15617 2Derma Sciences Raises 246 1 Million Through Private Placement 15617 3
Other Contentsseniorsseniorsseniorsseniorssenilitycanalscanalscanalscanalssepsissepsissepsissepsisanxietyanxietyanxietyanxietyanxietyseparationseparationseparationseparationseparationseparationseparationseparationsepticemiasepticemia